Wen Fury1, Keun Woo Park2,3, Zhuhao Wu4,5, Eunhee Kim2,6, Moon-Sook Woo2, Yu Bai1, Lynn E Macdonald1, Susan D Croll1, Sunghee Cho2,3. 1. Regeneron Pharmaceuticals, Tarrytown, NY (W.F., Y.B., L.E.M., S.D.C.). 2. Burke Neurological Institute, White Plains, NY (K.W.P., E.K., M.-s.W., S.C.). 3. Feil Brain Mind Research Institute, Weill Cornell Medicine, New York, NY (K.W.P., S.C.). 4. Departments of Cell, Developmental and Regenerative Biology (Z.W.), Icahn School of Medicine at Mount Sinai, New York, NY. 5. Neuroscience (Z.W.), Icahn School of Medicine at Mount Sinai, New York, NY. 6. Vivian L. Smith Department of Neurosurgery at University of Texas Health Science Center at Houston (E.K.).
Abstract
BACKGROUND AND PURPOSE: Stroke is a major cause of chronic neurological disability. There is considerable interest in understanding how acute transcriptome changes evolve into subacute and chronic patterns that facilitate or limit spontaneous recovery. Here we mapped longitudinal changes in gene expression at multiple time points after stroke in mice out to 6 months. METHODS: Adult C57BL/6 mice were subjected to transient middle cerebral artery occlusion. Longitudinal transcriptome levels were measured at 10 time points after stroke from acute to recovery phases of ischemic stroke. Localization and the number of mononuclear phagocytes were determined in the postischemic brain. Whole-mount brain imaging was performed in asplenic mice receiving GFP+ (green fluorescent protein)-tagged splenocytes. RESULTS: Sustained stroke-induced mRNA abundance changes were observed in both hemispheres with 2989 ipsilateral and 822 contralateral genes significantly perturbed. In the hemisphere ipsilateral to the infarct, genes associated with immune functions were strongly affected, including temporally overlapping innate and adaptive immunity and macrophage M1 and M2 phenotype-related genes. The strong immune gene activation was accompanied by the sustained infiltration of peripheral immune cells at acute, subacute, and recovery stages of stroke. The infiltrated immune cells were found in the infarcted area but also in remote regions at 2 months after stroke. CONCLUSIONS: The study identifies that immune components are the predominant molecular signatures and they may propagate or continuously respond to brain injury in the subacute to chronic phase after central nervous system injury. The study suggests a potential immune-based strategy to modify injury progression and tissue remodeling in ischemic stroke, even months after the initiating event.
BACKGROUND AND PURPOSE:Stroke is a major cause of chronic neurological disability. There is considerable interest in understanding how acute transcriptome changes evolve into subacute and chronic patterns that facilitate or limit spontaneous recovery. Here we mapped longitudinal changes in gene expression at multiple time points after stroke in mice out to 6 months. METHODS: Adult C57BL/6 mice were subjected to transient middle cerebral artery occlusion. Longitudinal transcriptome levels were measured at 10 time points after stroke from acute to recovery phases of ischemic stroke. Localization and the number of mononuclear phagocytes were determined in the postischemic brain. Whole-mount brain imaging was performed in asplenic mice receiving GFP+ (green fluorescent protein)-tagged splenocytes. RESULTS: Sustained stroke-induced mRNA abundance changes were observed in both hemispheres with 2989 ipsilateral and 822 contralateral genes significantly perturbed. In the hemisphere ipsilateral to the infarct, genes associated with immune functions were strongly affected, including temporally overlapping innate and adaptive immunity and macrophage M1 and M2 phenotype-related genes. The strong immune gene activation was accompanied by the sustained infiltration of peripheral immune cells at acute, subacute, and recovery stages of stroke. The infiltrated immune cells were found in the infarcted area but also in remote regions at 2 months after stroke. CONCLUSIONS: The study identifies that immune components are the predominant molecular signatures and they may propagate or continuously respond to brain injury in the subacute to chronic phase after central nervous system injury. The study suggests a potential immune-based strategy to modify injury progression and tissue remodeling in ischemic stroke, even months after the initiating event.
Authors: Nawaf Yassi; Charles B Malpas; Bruce C V Campbell; Bradford Moffat; Christopher Steward; Mark W Parsons; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis; Andrew Bivard Journal: Cerebrovasc Dis Date: 2015-03-25 Impact factor: 2.762
Authors: Meredith J Crane; Jean M Daley; Olivier van Houtte; Samielle K Brancato; William L Henry; Jorge E Albina Journal: PLoS One Date: 2014-01-22 Impact factor: 3.240
Authors: Ivan B Filippenkov; Julia A Remizova; Alina E Denisova; Vasily V Stavchansky; Ksenia D Golovina; Leonid V Gubsky; Svetlana A Limborska; Lyudmila V Dergunova Journal: Int J Mol Sci Date: 2022-06-30 Impact factor: 6.208
Authors: Vanessa H Brait; David K Wright; Mohsen Nategh; Alexander Oman; Warda T Syeda; Charlotte M Ermine; Katrina R O'Brien; Emilio Werden; Leonid Churilov; Leigh A Johnston; Lachlan H Thompson; Jess Nithianantharajah; Katherine A Jackman; Amy Brodtmann Journal: Sci Rep Date: 2021-05-13 Impact factor: 4.379